Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor canal block versus intra-articular catheter for pain relief after total knee replacement
ACTRN12615001139561Phase 4Completed
- Sponsor
- Orthopaedics Western Australia
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ropivacaine, dexamethasone, ketorolac and epinephrine in knee osteoarthritis (OA) (2 arms), sponsored by Orthopaedics Western Australia. Primary endpoints: Pain intensity and Range of movement of the operated knee. Started Jul 2016; status: completed.
02
Drugs
ropivacainedexamethasoneketorolacepinephrine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12615001139561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001139561.